# Safety Insurance Group Inc: financial statements, quarterly

SAFT · Nasdaq · CIK 1172052 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/saft.md) · [Financials](/companies/saft/financials.md) · [Filings](/companies/saft/filings.md) · [Insiders](/companies/saft/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/saft/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [229](/filings/0001172052-24-000040.md) | [258 d](/filings/0001172052-26-000005.md) | [268](/filings/0001172052-25-000019.md) | [270](/filings/0001172052-25-000030.md) | [295](/filings/0001172052-25-000036.md) | [287 d](/filings/0001172052-26-000005.md) | [301](/filings/0001172052-26-000015.md) | [316](/filings/0001172052-26-000023.md) | [327](/filings/0001172052-25-000036.md) | [319 d](/filings/0001172052-26-000005.md) | [315](/filings/0001172052-26-000015.md) | [326](/filings/0001172052-26-000023.md) |
| Interest expense | $m | [0.1](/filings/0001172052-23-000036.md) | [0.1 d](/filings/0001172052-24-000008.md) | [0.1](/filings/0001172052-24-000023.md) | [0.1](/filings/0001172052-25-000030.md) | [0.1](/filings/0001172052-25-000036.md) | [0.1 d](/filings/0001172052-26-000005.md) | [0.1](/filings/0001172052-26-000015.md) | [0.4](/filings/0001172052-26-000023.md) | [0.4](/filings/0001172052-25-000036.md) | [0.6 d](/filings/0001172052-26-000005.md) | [0.6](/filings/0001172052-26-000015.md) | [0.8](/filings/0001172052-26-000023.md) |
| Income tax | $m | [0.5](/filings/0001172052-24-000040.md) | [3.5 d](/filings/0001172052-26-000005.md) | [5.5](/filings/0001172052-25-000019.md) | [4.6](/filings/0001172052-25-000030.md) | [7.0](/filings/0001172052-25-000036.md) | [2.0 d](/filings/0001172052-26-000005.md) | [6.3](/filings/0001172052-26-000015.md) | [7.9](/filings/0001172052-26-000023.md) | [7.9](/filings/0001172052-25-000036.md) | [5.3 d](/filings/0001172052-26-000005.md) | [(3.5)](/filings/0001172052-26-000015.md) | [9.2](/filings/0001172052-26-000023.md) |
| Net income | $m | [1.9](/filings/0001172052-24-000040.md) | [12.3 d](/filings/0001172052-26-000005.md) | [20.1](/filings/0001172052-25-000036.md) | [16.6](/filings/0001172052-25-000036.md) | [25.9](/filings/0001172052-25-000036.md) | [8.1 d](/filings/0001172052-26-000005.md) | [21.9](/filings/0001172052-26-000023.md) | [28.9](/filings/0001172052-26-000023.md) | [28.3](/filings/0001172052-25-000036.md) | [20.1 d](/filings/0001172052-26-000005.md) | [(14.3)](/filings/0001172052-26-000023.md) | [34.5](/filings/0001172052-26-000023.md) |
| Diluted EPS | $ per share | [0.13](/filings/0001172052-24-000040.md) | not reported | [1.36](/filings/0001172052-25-000019.md) | [1.13](/filings/0001172052-25-000030.md) | [1.73](/filings/0001172052-25-000036.md) | not reported | [1.48](/filings/0001172052-26-000015.md) | [1.95](/filings/0001172052-26-000023.md) | [1.91](/filings/0001172052-25-000036.md) | not reported | [(0.99)](/filings/0001172052-26-000015.md) | [2.36](/filings/0001172052-26-000023.md) |
| Basic EPS | $ per share | [0.13](/filings/0001172052-24-000040.md) | not reported | [1.36](/filings/0001172052-25-000019.md) | [1.13](/filings/0001172052-25-000030.md) | [1.74](/filings/0001172052-25-000036.md) | not reported | [1.48](/filings/0001172052-26-000015.md) | [1.95](/filings/0001172052-26-000023.md) | [1.91](/filings/0001172052-25-000036.md) | not reported | [(0.99)](/filings/0001172052-26-000015.md) | [2.36](/filings/0001172052-26-000023.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.9](/filings/0001172052-23-000036.md) | [38.2](/filings/0001172052-25-000006.md) | [30.8](/filings/0001172052-24-000023.md) | [44.6](/filings/0001172052-24-000035.md) | [62.6](/filings/0001172052-24-000040.md) | [59.0](/filings/0001172052-26-000005.md) | [64.7](/filings/0001172052-25-000019.md) | [49.4](/filings/0001172052-25-000030.md) | [56.2](/filings/0001172052-25-000036.md) | [73.9](/filings/0001172052-26-000023.md) | [54.8](/filings/0001172052-26-000015.md) | [67.9](/filings/0001172052-26-000023.md) |
| Total assets | $m | [2,052](/filings/0001172052-23-000036.md) | [2,094](/filings/0001172052-25-000006.md) | [2,093](/filings/0001172052-24-000023.md) | [2,162](/filings/0001172052-24-000035.md) | [2,271](/filings/0001172052-24-000040.md) | [2,270](/filings/0001172052-26-000005.md) | [2,291](/filings/0001172052-25-000019.md) | [2,364](/filings/0001172052-25-000030.md) | [2,450](/filings/0001172052-25-000036.md) | [2,471](/filings/0001172052-26-000023.md) | [2,435](/filings/0001172052-26-000015.md) | [2,503](/filings/0001172052-26-000023.md) |
| Total liabilities | $m | [1,282](/filings/0001172052-23-000036.md) | [1,290](/filings/0001172052-25-000006.md) | [1,286](/filings/0001172052-24-000023.md) | [1,352](/filings/0001172052-24-000035.md) | [1,419](/filings/0001172052-24-000040.md) | [1,442](/filings/0001172052-26-000005.md) | [1,441](/filings/0001172052-25-000019.md) | [1,491](/filings/0001172052-25-000030.md) | [1,550](/filings/0001172052-25-000036.md) | [1,579](/filings/0001172052-26-000023.md) | [1,579](/filings/0001172052-26-000015.md) | [1,627](/filings/0001172052-26-000023.md) |
| Long-term debt | $m | not reported | [30.0](/filings/0001172052-25-000006.md) | not reported | not reported | not reported | not reported | [30.0](/filings/0001172052-25-000019.md) | [30.0](/filings/0001172052-25-000030.md) | [30.0](/filings/0001172052-25-000036.md) | [50.0](/filings/0001172052-26-000023.md) | [50.0](/filings/0001172052-26-000015.md) | [50.0](/filings/0001172052-26-000023.md) |
| Short-term borrowings | $m | not reported | not reported | [30.0](/filings/0001172052-24-000023.md) | [30.0](/filings/0001172052-24-000035.md) | [30.0](/filings/0001172052-24-000040.md) | [30.0](/filings/0001172052-26-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [770](/filings/0001172052-24-000040.md) | [804](/filings/0001172052-26-000005.md) | [807](/filings/0001172052-25-000036.md) | [810](/filings/0001172052-25-000036.md) | [851](/filings/0001172052-25-000036.md) | [828](/filings/0001172052-26-000023.md) | [851](/filings/0001172052-26-000023.md) | [873](/filings/0001172052-26-000023.md) | [900](/filings/0001172052-25-000036.md) | [892](/filings/0001172052-26-000023.md) | [856](/filings/0001172052-26-000023.md) | [877](/filings/0001172052-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [30.5 d](/filings/0001172052-24-000040.md) | [35.1 d](/filings/0001172052-26-000005.md) | [(21.1)](/filings/0001172052-25-000019.md) | [25.6 d](/filings/0001172052-25-000030.md) | [73.8 d](/filings/0001172052-25-000036.md) | [50.4 d](/filings/0001172052-26-000005.md) | [3.2](/filings/0001172052-26-000015.md) | [32.3 d](/filings/0001172052-26-000023.md) | [85.5 d](/filings/0001172052-25-000036.md) | [73.6 d](/filings/0001172052-26-000005.md) | [(17.0)](/filings/0001172052-26-000015.md) | [38.3 d](/filings/0001172052-26-000023.md) |
| Capital expenditure | $m | [0.9 d](/filings/0001172052-24-000040.md) | [0.4 d](/filings/0001172052-26-000005.md) | [3.1](/filings/0001172052-25-000019.md) | [0.5 d](/filings/0001172052-25-000030.md) | [0.6 d](/filings/0001172052-25-000036.md) | [0.2 d](/filings/0001172052-26-000005.md) | [0.3](/filings/0001172052-26-000015.md) | [0.1 d](/filings/0001172052-26-000023.md) | [0.0 d](/filings/0001172052-25-000036.md) | [2.1 d](/filings/0001172052-26-000005.md) | [1.8](/filings/0001172052-26-000015.md) | [0.6 d](/filings/0001172052-26-000023.md) |
| Dividends paid | $m | [13.2 d](/filings/0001172052-24-000040.md) | [13.2 d](/filings/0001172052-26-000005.md) | [13.6](/filings/0001172052-25-000019.md) | [13.2 d](/filings/0001172052-25-000030.md) | [13.2 d](/filings/0001172052-25-000036.md) | [13.2 d](/filings/0001172052-26-000005.md) | [13.6](/filings/0001172052-26-000015.md) | [13.3 d](/filings/0001172052-26-000023.md) | [13.6 d](/filings/0001172052-25-000036.md) | [13.5 d](/filings/0001172052-26-000005.md) | [13.6](/filings/0001172052-26-000015.md) | [13.4 d](/filings/0001172052-26-000023.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.7](/filings/0001172052-23-000036.md) | [14.8](/filings/0001172052-24-000023.md) | [14.7](/filings/0001172052-24-000035.md) | [14.7](/filings/0001172052-24-000040.md) | [14.7](/filings/0001172052-25-000019.md) | [14.7](/filings/0001172052-25-000030.md) | [14.9](/filings/0001172052-25-000036.md) | [14.7](/filings/0001172052-26-000015.md) | [14.8](/filings/0001172052-26-000023.md) | [14.8](/filings/0001172052-25-000036.md) | [14.5](/filings/0001172052-26-000015.md) | [14.6](/filings/0001172052-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,680,482 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001172052-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.